Correlation Between Compass Therapeutics and Lyra Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Compass Therapeutics and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Compass Therapeutics and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Compass Therapeutics and Lyra Therapeutics, you can compare the effects of market volatilities on Compass Therapeutics and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Compass Therapeutics with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Compass Therapeutics and Lyra Therapeutics.

Diversification Opportunities for Compass Therapeutics and Lyra Therapeutics

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Compass and Lyra is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Compass Therapeutics and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Compass Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Compass Therapeutics are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Compass Therapeutics i.e., Compass Therapeutics and Lyra Therapeutics go up and down completely randomly.

Pair Corralation between Compass Therapeutics and Lyra Therapeutics

Given the investment horizon of 90 days Compass Therapeutics is expected to generate 0.72 times more return on investment than Lyra Therapeutics. However, Compass Therapeutics is 1.39 times less risky than Lyra Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.06 per unit of risk. If you would invest  325.00  in Compass Therapeutics on August 28, 2024 and sell it today you would lose (175.00) from holding Compass Therapeutics or give up 53.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.72%
ValuesDaily Returns

Compass Therapeutics  vs.  Lyra Therapeutics

 Performance 
       Timeline  
Compass Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Compass Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Compass Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Lyra Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lyra Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Compass Therapeutics and Lyra Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Compass Therapeutics and Lyra Therapeutics

The main advantage of trading using opposite Compass Therapeutics and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Compass Therapeutics position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.
The idea behind Compass Therapeutics and Lyra Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities